OPN5 and B-cell chronic lymphocytic leukemia: Overall, these data demonstrate that BRD4 inhibition by OPN5 clearly alleviates the immune-suppressive capacity of Eμ-TCL1-derived MDSCs, indicating a role for BRD4 and other BET proteins in MDSC-mediated immune suppression in CLL.